Pacific Biosciences of California, Inc. (PACB) stock
PACBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
$1.82−0.02 (-1.09%)
Close on Nov 17, 2026Market cap $565.71MP/E –Yield 0.00%
Pacific Biosciences of California price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pacific Biosciences of California's price to sales ratio was 4.1× on Nov 11, 2026, against 4.5× a year earlier. Over the last 5 years it ranged from 1.9× to 37.1×, with a median of 4.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.1× | +0.4 |
| 2025 | Dec 31, 2025 | 3.7× | +0.8 |
| 2024 | Dec 31, 2024 | 2.9× | −12.1 |
| 2023 | Dec 29, 2023 | 15.0× | +1.5 |
| 2022 | Dec 30, 2022 | 13.5× | −23.6 |
| 2021 | Dec 31, 2021 | 37.1× | −20.0 |
| 2020 | Dec 31, 2020 | 57.1× | +47.6 |
| 2019 | Dec 31, 2019 | 9.5× | −3.6 |
| 2018 | Dec 31, 2018 | 13.1× | +9.9 |
| 2017 | Dec 29, 2017 | 3.3× | −0.2 |
| 2016 | Dec 30, 2016 | 3.5× | −10.1 |
| 2015 | Dec 31, 2015 | 13.5× | +3.0 |
| 2014 | Dec 31, 2014 | 10.5× | −3.3 |
| 2013 | Dec 31, 2013 | 13.9× | +10.9 |
| 2012 | Dec 31, 2012 | 2.9× | −4.1 |
| 2011 | Dec 30, 2011 | 7.1× | – |
See a number that looks wrong?